Investing.com - Financial Markets Worldwide

US STOCKS SNAPSHOT-Futures jump after Gilead's COVID-19 drug meets main goal

Published 29/04/2020, 13:51
US STOCKS SNAPSHOT-Futures jump after Gilead's COVID-19 drug meets main goal
GILD
-

April 29 (Reuters) - U.S. stock index futures jumped on
Wednesday after Gilead Sciences GILD.O said its experimental
antiviral drug met the main goal of a trial testing it in
COVID-19 patients. Meanwhile, the U.S. economy contracted in the first quarter
at its sharpest pace since the Great Recession, ending the
longest expansion in history. Data from the Commerce Department said gross domestic
product fell at a 4.8% annualized rate in the January-to-March
period, while economists in a Reuters poll were expecting a
contraction of 4%.
At 08:46 a.m. ET, Dow e-minis 1YMcv1 were up 330 points,
or 1.37%. S&P 500 e-minis EScv1 were up 38.5 points, or 1.34%
and Nasdaq 100 e-minis NQcv1 were up 123 points, or 1.41%.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.